chitosan has been researched along with nimodipine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, J; Ali, M; Hassan, N | 1 |
| Jiang, T; Liu, Y; Wang, S; Wang, Y; Xie, Y | 1 |
| Gao, Y; Jiang, T; Sun, H; Wang, S; Xie, Y; Zhao, Q; Zheng, X | 1 |
| Abd-Elgawad, AH; El-Dahan, MS; Jablonski, MM; Maria, DN; Soliman, OA | 1 |
| Abdelghafour, MM; Bari, F; Bozó, É; Csapó, E; Deák, Á; Dékány, I; Farkas, E; Janovák, L; Juhász, Á; Mérai, L; Sebők, D; Turcsányi, Á | 1 |
| Bari, F; Dékány, I; Farkas, E; Hantosi, D; Ivánkovits-Kiss, O; Janovák, L; Menyhárt, Á; Szabó, Í; Tóth, OM; Varga, DP; Varga, VÉ | 1 |
6 other study(ies) available for chitosan and nimodipine
| Article | Year |
|---|---|
Development and evaluation of novel buccoadhesive wafers of nimodipine for treatment of hypertension.
Topics: Acrylic Resins; Adhesiveness; Administration, Buccal; Animals; Antihypertensive Agents; Biological Availability; Carboxymethylcellulose Sodium; Chitosan; Diffusion; Dosage Forms; Drug Carriers; Drug Delivery Systems; Drug Stability; Excipients; Hydrogen-Ion Concentration; Hypertension; Mouth Mucosa; Nimodipine; Pharmaceutical Preparations; Rabbits; Solubility; Technology, Pharmaceutical; Viscosity | 2010 |
Chitosan matrix with three dimensionally ordered macroporous structure for nimodipine release.
Topics: Calorimetry, Differential Scanning; Chitosan; Drug Carriers; Hydrogen-Ion Concentration; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanostructures; Nimodipine; Nitrogen; Particle Size; Solubility; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2012 |
Effect of pore size of three-dimensionally ordered macroporous chitosan-silica matrix on solubility, drug release, and oral bioavailability of loaded-nimodipine.
Topics: Administration, Oral; Animals; Biological Availability; Chitosan; Drug Carriers; Drug Liberation; Molecular Conformation; Nimodipine; Porosity; Rats; Rats, Sprague-Dawley; Silicon Dioxide | 2016 |
Nimodipine Ophthalmic Formulations for Management of Glaucoma.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Ophthalmic; Animals; beta-Cyclodextrins; Chemistry, Pharmaceutical; Chitosan; Drug Liberation; Freeze Drying; Glaucoma; Hypromellose Derivatives; Intraocular Pressure; Mice, Inbred C57BL; Nimodipine; Ophthalmic Solutions | 2017 |
Preparation of novel tissue acidosis-responsive chitosan drug nanoparticles: Characterization and in vitro release properties of Ca
Topics: Acidosis; Calcium Channel Blockers; Chitosan; Drug Carriers; Drug Liberation; Humans; Nanoparticles; Nimodipine | 2018 |
Chitosan nanoparticles release nimodipine in response to tissue acidosis to attenuate spreading depolarization evoked during forebrain ischemia.
Topics: Acidosis; Animals; Biocompatible Materials; Brain Ischemia; Calcium Channel Blockers; Carotid Artery, Common; Cell Survival; Cerebrovascular Circulation; Chitosan; Cortical Spreading Depression; Drug Carriers; Drug Delivery Systems; Hydrogen-Ion Concentration; Microglia; Nanoparticles; Neurons; Nimodipine; Prosencephalon; Rats | 2020 |